These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3871585)

  • 1. Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease.
    Takahashi H; Nagayama R; Hattori A; Shibata A
    Am J Hematol; 1985 Feb; 18(2):179-89. PubMed ID: 3871585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane.
    Howard MA; Perkin J; Salem HH; Firkin BG
    Br J Haematol; 1984 May; 57(1):25-35. PubMed ID: 6426499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets.
    Nishio K; Fujimura Y; Niinomi K; Takahashi Y; Yoshioka A; Fukui H; Usami Y; Titani K; Ruggeri ZM; Zimmerman TS
    Am J Hematol; 1990 Apr; 33(4):261-6. PubMed ID: 2316510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
    Matsui T; Hori A; Hamako J; Matsushita F; Ozeki Y; Sakurai Y; Hayakawa M; Matsumoto M; Fujimura Y
    J Thromb Haemost; 2017 Mar; 15(3):538-548. PubMed ID: 28071872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin.
    Coller BS
    Blood; 1980 Feb; 55(2):276-81. PubMed ID: 6766335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of von Willebrand factor activity elicited by ristocetin and botrocetin: studies on a human von Willebrand factor-binding antibody.
    Brinkhous KM; Fricke WA; Read MS
    Semin Thromb Hemost; 1985 Oct; 11(4):337-41. PubMed ID: 2416059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728.
    Fujimura Y; Holland LZ; Ruggeri ZM; Zimmerman TS
    Blood; 1987 Oct; 70(4):985-8. PubMed ID: 3498523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor.
    Mohri H; Tanabe J; Ohtsuka M; Yoshida M; Motomura S; Nishida S; Fujimura Y; Okubo T
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):561-6. PubMed ID: 7578899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A paradoxical effect of antibody concentration on vWF-dependent platelet agglutination distinguishes between botrocetin and ristocetin-induced agglutination.
    Roberson DW; Upchurch GR; Lamb MA; Read MS; Wagner RH; Cooper HA
    Thromb Res; 1986 Dec; 44(6):749-60. PubMed ID: 3492062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.